Filing Details
- Accession Number:
- 0001209191-17-039817
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-14 16:18:16
- Reporting Period:
- 2017-06-12
- Filing Date:
- 2017-06-14
- Accepted Time:
- 2017-06-14 16:18:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578251 | T. Jeffrey Walsh | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Financial | No | Yes | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-12 | 2,500 | $2.09 | 29,805 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-12 | 1,919 | $109.26 | 27,886 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 579 | $110.42 | 27,307 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 2 | $111.10 | 27,305 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-12 | 2,500 | $0.00 | 2,500 | $2.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,236 | 2021-07-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2016.
- The range of prices for the transaction reported on this line was $108.90 to $109.75. The average weighted price was $109.2645. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $110.05 to $111.00. The average weighted price was $110.4155. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
